SCHEMBL7345146

SCHEMBL7345146

CC(C)[C@H](C[C@H](O)[C@H](C)NC(=O)OC(C)(C)C)C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.48
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA7 P43166 2/20 0.45
CTSK P43235 7/20 0.40
CTSS P25774 2/20 0.40
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
BACE1 P56817 2/20 0.36
APP P05067 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
CA4 P22748 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9263938 0.81 CYP2D6 (0.42) CYP2D6CA1CA2CA7CTSK
SCHEMBL7412829 0.81 CYP2D6 (0.42) CYP2D6CA1CA2CA7CTSK
SCHEMBL19790304 0.81 CA1 (0.53) CYP2D6CA1CA2CA7CTSK
SCHEMBL14923535 0.81 CA1 (0.53) CYP2D6CA1CA2CA7CTSK
SCHEMBL6623815 0.78 CYP2D6 (0.51) CYP2D6CA1CA2CA7CTSK
SCHEMBL14384109 0.78 CYP2D6 (0.51) CYP2D6CA1CA2CA7CTSK
SCHEMBL6637263 0.78 CYP2D6 (0.51) CYP2D6CA1CA2CA7CTSK
SCHEMBL17282912 0.78 CYP2D6 (0.51) CYP2D6CA1CA2CA7CTSK
SCHEMBL14384110 0.78 CYP2D6 (0.51) CYP2D6CA1CA2CA7CTSK
SCHEMBL9262937 0.78 CYP2D6 (0.41) CYP2D6CA1CA2CA7CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5389647-A A prodrugs as hypotensive agents, treating congestive heart failure, urogenital disorders, vision defects ABBOTT LABORATORIES (US) 1995-02-14 US disclosed
US-5244910-A Treating hypertension, congestive heart failure ABBOTT LABORATORIES (US) 1993-09-14 US disclosed
WO-1992003429-A1 RENIN INHIBITORS ABBOTT LABORATORIES (US) 1992-03-05 WO disclosed